Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Case Series
Corrigendum
Editorial
From the BISI office
Guest Editorial
Original Research
Pictorial Essay
Review Article
Reviewers
Technical Note/Innovation
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Case Series
Corrigendum
Editorial
From the BISI office
Guest Editorial
Original Research
Pictorial Essay
Review Article
Reviewers
Technical Note/Innovation
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Case Series
Corrigendum
Editorial
From the BISI office
Guest Editorial
Original Research
Pictorial Essay
Review Article
Reviewers
Technical Note/Innovation
View/Download PDF

Translate this page into:

Original Research
3 (
2
); 63-69
doi:
10.25259/IJBI_10_2025

Evaluation of T2 weighted hyperintense lesions on breast MRI: Imaging characteristics and histopathology correlation

Department of Interventional Radiology, Dr. D. Y. Patil Medical College, Hospital & Research Centre, Pune, India
Department of Pathology, Dr. D. Y. Patil Medical College, Hospital & Research Centre, Pune, India

*Corresponding author: Pratiksha Yadav, Department of Interventional Radiology, Dr. D. Y. Patil Medical College, Hospital & Research Centre, Pune, India. yadavpratiksha@hotmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Yadav P, Gore C. Evaluation of T2 weighted hyperintense lesions on breast MRI: Imaging characteristics and his topathology correlation. Indian J Breast Imaging. 2025;3:63–69. doi: 10.25259/IJBI_10_2025

Abstract

Objectives

To evaluate the imaging characteristics of T2-weighted hyperintense lesions on T1WI, dynamic contrast Fat Sat T1WI, and the correlation of these features with histopathology findings.

Materials and Methods

This is a retrospective observational study carried out in a tertiary care hospital. MRI breast images were analyzed in 107 T2W hyperintense lesions. The imaging characteristics in the form of signal intensity, shape, margins, and kinetic pattern were evaluated, and the findings were correlated with histopathology findings.

Results

Out of the 107 lesions, 86 (80.4%) were benign and 21 (19.6%) were malignant. The most common benign pathology was fibroadenoma (33.7%), followed by cysts (20.9%) and infection or abscess (18.6%). The most common malignant pathology was invasive ductal carcinoma (42.8%), followed by papillary carcinoma (19%) and mucinous cancer (14.2%). The most common shape was irregular, which was present in 47.6% (n = 51, 34 benign and 17 malignant), followed by the oval shape at 39.2% (n = 42, 39 benign and 3 malignant). Circumscribed margins were seen in 67% of masses (n = 72, 69 benign, 3 malignant), and spiculated margins were observed in 52.4% of malignant masses. Type I kinetic curve was seen in 54.21% (n = 58) of lesions, type II in 32.71% (n = 35), and a type III in 13.08% (n = 14). Twelve out of 21 malignant lesions showed type III curve, and 58 out of 86 benign lesions showed a type I curve.

Conclusion

The T2WI sequence is useful in evaluating breast masses on MRI. It helps diagnose edema, cysts, fat, fluid collection, hemorrhage, and tumor necrosis in the breast lesions. Malignant lesions of mucinous, papillary, and medullary cancers demonstrate hyperintense signal intensities on T2-weighted imaging, and these findings aid the diagnosis of these cases in clinical practice. The T2W imaging sequence in the abbreviated protocol improves the diagnostic accuracy.

Keywords

Breast MRI
Invasive cancers
Malignant
Mucinous cancers
Papillary cancers

INTRODUCTION

Differential diagnosis of the breast masses on contrast-enhanced MR imaging is based on the morphology, the comparative signal intensity of the lesions on T2WI (T2-weighted images), T1WI (T1-weighted images), and dynamic contrast fat sat T1W images. T2W hyperintense signal intensity lesions are brighter than the normal parenchyma. These can include benign, malignant, infectious, or inflammatory pathologies. Characterization of the lesion on T2WI, along with pre-contrast fat-suppressed T1WI and a dynamic post-contrast study helps to improve diagnostic accuracy on imaging. Various abbreviated MRI protocols use only pre-contrast T1WI and 3 dynamic post-contrast sequences.[1] There were a few other studies that have included T2WI in their evaluation. T2W hyperintensity can be due to cyst/fluid content, microcystic component, myxoid or mucinous stroma, necrosis, hemorrhage, or edema.[2] Fat and fluid both appear bright on T2WI, and it is essential to differentiate both components in the lesion. Where fat suppression (FS) sequence helps to differentiate the two; non-FS T2WI provides better information about morphology and architectural distortion. In breast tissue, edema can be due to trauma, hemorrhage, inflammation, infective pathologies, post-radiation changes, or lymphatic congestion. Various benign and malignant breast pathologies can demonstrate variable patterns of the MR imaging spectrum.[3] A T2-weighted sequence before dynamic contrast-enhanced MRI is useful in the characterization of breast lesions.[4,5] Inflammation associated with necrosis may also lead to stromal edema; tumor necrosis and perilesional edema are usually seen in high-grade cancers and demonstrate hyperintense signals on T2WI.[6] Tumor necrosis demonstrate hyperintense signal intensity on T2WI; however, fat necrosis may present hypointense signals within the fatty island sign. On the other hand, mucinous carcinoma consists of a large amount of epithelial mucin, which is hyperintense on T2WI.[7] Careful analysis of T2W imaging patterns of the lesions is useful to narrow the differential diagnosis and reduce false positive cases. In this study, we retrospectively analyzed imaging characteristics of various benign and malignant T2 hyperintense lesions and correlated them with histopathology findings to highlight the potential use of this particular sequence.

MATERIALS AND METHODS

It is an observational study performed in a tertiary care university hospital. It was approved by the institutional ethics committee. Dynamic contrast-enhanced MRI of breast studies of a total 144 cases were retrieved from PACS and analyzed. MRI of the breast were performed above 18 years of age on a 3 Tesla MRI scanner (MAGNETOM Vida, Siemens Healthcare, Germany) using a dedicated 18-channel breast coil. MRI examination were performed in the prone position. A multiplaner localizer with a field of view (FOV) of 300–360 mm and 3 mm of slice thickness was applied. Sequences were used; pre-contrast T2WI (TR/TE 3000/71 ms), STIR (TR/TE 3800/70 ms), DWI imaging (TR/TE 6800/70 ms), and fat-suppressed T1WI (TR/TE 6.13/3.30 ms), followed by dynamic post-contrast fat-suppressed T1WI, were obtained in 0.8 mm slice thickness in 3-D transverse orientation with TR/TE of 4.54/1.73 ms. Multihance 0.1 mmol/kg body weight was injected with a pressure injector with a flow rate of 2.0 ml/s, followed by a flush of 20 ml of saline. Amongst these patients, 107 T2 hyperintense lesions were included for the study, and 37 hypointense lesions were excluded [Figure 1]. Each lesion was analyzed for characterization on STIR, non-FS T2WI, T1WI, and FS T1-Weighted dynamic post-contrast MR images. These findings were noted in the form of signal intensity, shape, margins, and kinetic patterns. Findings were correlated with histopathology findings, and the MRI features were analyzed in various benign and malignant lesions.

Study analyzed 107 mass lesions which showed hyperintense signal intensity on T2WI. 80.4% were benign and 19.6% were malignant lesions. 37 hypointense mass lesions were excluded.
Figure 1:
Study analyzed 107 mass lesions which showed hyperintense signal intensity on T2WI. 80.4% were benign and 19.6% were malignant lesions. 37 hypointense mass lesions were excluded.

RESULTS

Out of 107 hyperintense mass lesions, 80.4% (n = 86) were benign and 19.6% (n = 21) were malignant. [Figure 1]. Age range was 18–70 years (mean = 40.8). The most common benign pathology was fibroadenoma, found in 33.7% (n = 29) [Figure 2], followed by a cyst 20.9% (n = 18) and infection or abscess in 18.6% (n = 16) of cases. Intraductal papilloma was found in 7 (8.14%), [Figure 3] and benign phyllodes were observed in 5 (5.81%) cases [Figure 4]. Most common malignant pathology was invasive ductal carcinoma, 42.8% (n = 9) [Figure 5], followed by papillary carcinoma, 19% (n = 4), and mucinous cancer, 14.2% (n = 3) [Figure 6]. Two cases of lobular cancer and three malignant phyllodes also showed hyperintense signals on T2WI [Table 1]. The most common shape was irregular, which was present in 47.6% (n = 51) of cases (34 benign and 17 malignant), followed by oval shape. 39.2% (n = 42) (39 benign and 3 malignant) and 13% (n = 14) were round (13 benign and 1 malignant). Circumscribed margins were seen in 72 masses [69 benign, (80%) and 3 malignant, (14%)] followed by irregular in 23 [17 benign, (19%) and 7 malignant, (33%)]. Spiculated margins were observed in 52.4% (n = 11) of malignant masses [Table 2]. Perilesional edema and tumor necrosis were seen in 12 malignant lesions (57%). In dynamic contrast-enhanced study, 54.21% (n = 58) demonstrated a type I curve, 32.71% (n = 35) a type II, and 13.08% (n = 14) a type III kinetic curve. Twelve of the malignant lesions showed a type III curve (57%), and five showed a type II curve. Most of the benign lesions (58/86, 67%) showed a type I curve. Lesion characteristics on MRI have been elaborated in Table 3.

MRI of fibroadenoma. (a) Axial Fat sat T2WI revealed a well defined, oval hyperintense mass in left breast (blue arrow), (b) Fat-suppressed axial DCE-MRI revealed persistent homogeneous enhancement (blue arrow), (c) Proliferating glandular elements (wide blue arrow) showing mixed growth pattern. The glands are bilayered with fibromyxoid stroma (narrow blue arrow). (Hematoxylin and eosin, x400). DCE-MRI: Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Figure 2:
MRI of fibroadenoma. (a) Axial Fat sat T2WI revealed a well defined, oval hyperintense mass in left breast (blue arrow), (b) Fat-suppressed axial DCE-MRI revealed persistent homogeneous enhancement (blue arrow), (c) Proliferating glandular elements (wide blue arrow) showing mixed growth pattern. The glands are bilayered with fibromyxoid stroma (narrow blue arrow). (Hematoxylin and eosin, x400). DCE-MRI: Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Case of intraductal papilloma. (a) Axial Short tau inversion recovery T2WI of left breast showing an oval complex cystic mass (blue arrow) with an irregular mass from lateral wall (white arrow) and few hypointense septations. (b) Well-formed fibrovascular fronds (wide blue arrow), (H and E, x100) and presence of two cell types: epithelial and myoepithelial within the papillae (narrow blue arrow) (inset: H and E, x400). H and E: Hematoxylin and eosin.
Figure 3:
Case of intraductal papilloma. (a) Axial Short tau inversion recovery T2WI of left breast showing an oval complex cystic mass (blue arrow) with an irregular mass from lateral wall (white arrow) and few hypointense septations. (b) Well-formed fibrovascular fronds (wide blue arrow), (H and E, x100) and presence of two cell types: epithelial and myoepithelial within the papillae (narrow blue arrow) (inset: H and E, x400). H and E: Hematoxylin and eosin.
MRI in phyllodes. (a) T2 Short tau inversion recovery Axial MRI of breast revealed an irregular mass with hyperintense cystic component (blue arrow) and hypointense internal septae (white arrow), (b) Post contrast MRI showed heterogeneous enhancement with non enhancing hypointense septae (white arrow) and cystic areas (blue arrow), (c) Benign phyllodes tumor; leaf like architecture with biphasic hyperplastic epithelium (wide blue arrow) and variable stromal cellularity (narrow blue arrow) (Hematoxylin and eosin, x100). MRI: Magnetic resonance imaging.
Figure 4:
MRI in phyllodes. (a) T2 Short tau inversion recovery Axial MRI of breast revealed an irregular mass with hyperintense cystic component (blue arrow) and hypointense internal septae (white arrow), (b) Post contrast MRI showed heterogeneous enhancement with non enhancing hypointense septae (white arrow) and cystic areas (blue arrow), (c) Benign phyllodes tumor; leaf like architecture with biphasic hyperplastic epithelium (wide blue arrow) and variable stromal cellularity (narrow blue arrow) (Hematoxylin and eosin, x100). MRI: Magnetic resonance imaging.
Case of infiltrating ductal carcinoma. (a) Axial Short tau inversion recovery T2WI showing mass in left breast showing hyperintense signals (blue arrow) and hyperintense perlesional edema (white arrow). (b) Axial dynamic contrast enhanced MRI fat sat subtracted image showing heterogeneous contrast enhancement with early wash out (blue arrow), (c) Histopathology of infiltrating ductal carcinoma not otherwise specified (NOS); infiltrating nests and trabeculae of malignant duct epithelial cells (blue arrow), (Hematoxylin and eosin, x100; inset x400). MRI: Magnetic resonance imaging.
Figure 5:
Case of infiltrating ductal carcinoma. (a) Axial Short tau inversion recovery T2WI showing mass in left breast showing hyperintense signals (blue arrow) and hyperintense perlesional edema (white arrow). (b) Axial dynamic contrast enhanced MRI fat sat subtracted image showing heterogeneous contrast enhancement with early wash out (blue arrow), (c) Histopathology of infiltrating ductal carcinoma not otherwise specified (NOS); infiltrating nests and trabeculae of malignant duct epithelial cells (blue arrow), (Hematoxylin and eosin, x100; inset x400). MRI: Magnetic resonance imaging.
Case of mucinous carcinoma. (a) Axial Short tau inversion recovery T2WI magnetic resonance imaging (MRI) of right breast revealed an oval mass with homogeneous hyperintense signal intensity and circumscribed margins (blue arrow). (b) Axial fat sat T1WI MRI showing mixed signals with hyperintense rim (blue arrow). (c and d) Histopathology showing clusters of tumor cells (wide blue arrow) surrounded by mucin (narrow blue arrow) (Hematoxylin and Eosin; x100, x400).
Figure 6:
Case of mucinous carcinoma. (a) Axial Short tau inversion recovery T2WI magnetic resonance imaging (MRI) of right breast revealed an oval mass with homogeneous hyperintense signal intensity and circumscribed margins (blue arrow). (b) Axial fat sat T1WI MRI showing mixed signals with hyperintense rim (blue arrow). (c and d) Histopathology showing clusters of tumor cells (wide blue arrow) surrounded by mucin (narrow blue arrow) (Hematoxylin and Eosin; x100, x400).
Table 1: Final histopathology result in 86 benign and 21 malignant masses.
Benign = 86 (80.4%)
Mass lesion n (%)
Fibroadenoma 29 (33.72%)
Cyst 18 (20.93%)
Infection 16 (18.60%)
Intraductal papilloma 7 (8.14%)
Phyllodes 5 (5.81%)
Fat necrosis 4 (4.65%)
Hamartoma 2 (2.33%)
Galactocele 3 (3.50%)
Lactating adenoma 1 (1.16%)
Hematoma 1 (1.16%)
Total 86 (100%)
Malignant = 21 (19.6%)
Intraductal carcinoma 9 (42.87%)
Papillary carcinoma 4 (19.04%)
Mucinous carcinoma 3 (14.28%)
Lobular carcinoma 2 (9.53%)
Malignant phyllodes 3 (14.28%)
Total 21 (100%)
Table 2: Morphology of the masses on T1WI and T2WI imaging.
Shape Benign Malignant
Oval (42) 39 (45.3%) 3 (14.3%)
Round (14) 13 (15.1%) 1 (4.8%)
Irregular (51) 34 (39.6%) 17 (80.9%)
Total 86 (100%) 21 (100%)
Margins
Circumscribed (72) 69 (80.2%) 3 (14.3%)
Irregular (23) 17 (19.8%) 7 (33.3%)
Spiculated (11) 0 (0%) 11 (52.4%)
Total 86 (100%) 21 (100%)
Table 3: Breast MRI characteristics of various benign and malignant lesions.
Lesion Morphology Signal intensity Enhancement
T1WI T2WI
Cyst Round or oval shape, circumscribed margins Hypointense Hyperintense No enhancement or thin peripheral rim enhancement
Fibroadenoma Oval or round shape, circumscribed margins Hypo to iso intense Hyperintense Persistent enhancement. Dark non-enhancing internal septae (Type I curve)
Intraductal papilloma Round, oval or variable intraductal mass Hypointense Hyperintense, hypointense mass may present Rim enhancement, enhancing intraductal mass, washout kinetic pattern (Type I or II curve)
Inflammatory/infective lesion Variable shape, non-mass hyperintensities, dilated ducts Hypointense sometimes shows hyperintense T1W signals in proteinaceous contents in duct Hyperintense, non -mass hyperintense signal intensities Peripheral rim enhancement, non-mass enhancement (Type I or II curve)
Benign Phyllodes Oval or round shape, circumscribed margins, clefts are present Hypointense Heterogeneous/patchy hyperintense signals, cystic areas Heterogeneous enhancement pattern (Type II curve)
Malignant Phyllodes Variable shape and margins Hypointense Heterogeneous/patchy hyperintense signals, cystic areas Heterogeneous enhancement with plateau (Type II) or early washout (Type III)
Papillary carcinoma Round, variable, intraductal mass Hypointense Hyperintense, hypointense mass may present Rim enhancement, enhancing septae, enhancing intraductal mass, and washout kinetic pattern (Type III kinetic curve)
Invasive ductal carcinoma Irregular shape, irregular or spiculated margins Hypointense Variable signal intensity, Heterogeneously hyper intense Heterogeneous, early washout kinetics (Type III curve)
Mucinous carcinoma Round, oval or lobulated. Circumscribed margins Variable signal intensity on T1WI depending upon protein composition Hyperintense Persistent, variable kinetic curves (Type II or III curve)
Lymph node Oval, circumscribed mass Hypointense with central hyperintense fatty hilum Hyperintense Homogeneous enhancement, Type III kinetic curve
Seroma/hematoma Round, circumscribed Hypointense Hyperintense Peripheral thin rim enhancement, Type I kinetic curve

DISCUSSION

Various benign and malignant lesions may demonstrate hyperintense signal intensity on T2WI. Pathology features that may demonstrate high signal intensity on T2WI are tumor necrosis, cystic components, mucinous or myxoid stroma, sebaceous or adipose contents, parenchymal edema, or hemorrhagic contents. Understanding the correlation between the MRI findings in specific pathological processes helps radiologists improve diagnostic accuracy.[2]

The most common breast malignancy includes invasive ductal carcinomas, which usually present as hypointense masses on T2WI with irregular or spiculated margins and heterogeneous enhancement on post-contrast sequence. Central necrosis may present in high-grade cancers and in large masses that appear T2 hyperintense. Tumor necrosis, histologically consisting of dead and degraded tumor cells and central infarcted tissue, accumulates as fluid and debris, which demonstrates T2WI hyperintense signal intensity. Analysis of tumor necrosis is important, as the presence of tumor necrosis is associated with poor prognosis.[6,8,9] Mucinous, invasive papillary, and metaplastic cancers are hyperintense on T2WI, as documented in various studies.[7,1013] In the present study also, T2 hyperintense masses included mucinous and papillary carcinomas. Histologically mucinous carcinomas are of two types: pure and mixed. On MRI they are round, oval, or lobular in shape and demonstrate circumscribed margins.[2,6] They show very high signal intensity on T2WI and variable signals on T1WI. On post-contrast study, most of the pure mucinous cancers demonstrate slow progressive enhancement; however, in mixed mucinous cancers, it may show heterogeneous enhancement with a variable kinetic pattern.[7] High-grade necrotic tumors show heterogeneous enhancement with a peripheral rim and early washout, type III kinetic curve.[6,8] In present study eight invasive ductal cancers and two invasive lobular cancers also showed T2 hyperintense tumor necrosis and perilesional edema.

The differential diagnosis amongst benign T2 hyperintense lesions includes cysts, which are amongst the most prevalent findings on breast imaging. Simple cysts do not show enhancement in post-contrast studies.[14] In our study, cysts demonstrated circumscribed margins and high signal intensities on T2WI but no enhancement, and abscesses showed peripheral rim enhancement and perilesional edema. Infected cysts showed peripheral rim enhancement, better seen on subtracted images. On histopathology cysts are fluid-filled spaces with epithelial linings. Infected cysts may contain inflammatory infiltrates, lymphocytes, and macrophages. Fat necrosis revealed hyperintense signal intensity on non-fat-suppressed T1WI and T2WI; on fat-suppressed T1WI and T2WI imaging, it shows similar signal intensity of adjacent fatty parenchyma. In the acute phase, it may show internal or peripheral post-contrast enhancement, but it reduces as development of fibrosis occurs.

Fibroadenomas are usually well-defined oval or round masses with circumscribed or lobulated margins. Due to glandular and stromal elements, these lesions show hyperintense signals on T2WI and iso- to hypointense on T1WI; hypointense septae may also be present within. In our study most of the fibroadenomas (21 out of 29) showed circumscribed margins. On histopathology, fibroadenomas are firm, well-circumscribed biphasic tumors with proliferation of both glandular and stromal elements. Glandular elements have retained the myoepithelial layer. The stromal component is generally of uniform cellularity and comprises collagen, bland spindle-shaped stromal cells with ovoid elongated nuclei, and no or rare mitotic activity observed.[15,16] The typical phyllodes tumor is round, relatively well circumscribed, and firm. On histopathology, phyllodes tumors are solid, grey-white, whorled, bosselated, and show a leaf-like pattern; they are biphasic tumors with stromal hypercellularity and benign glandular elements. These are graded into benign, borderline, and malignant depending on stromal atypia, stromal cellularity, stromal overgrowth, mitotic count, tumor border, and malignant heterologous elements. Cystic degeneration, hemorrhage, stromal hyalinization, and myxoid changes reported in phyllodes may lead to T2 hyperintensity.[16,17] The present study included 5 benign and 3 malignant phyllodes cases, and all of them showed hyperintense signal intensities on T2WI due to cystic and myxoid changes. Duman et al. observed that fibroadenomas are more ovoid in shape and phyllodes more frequently irregular in shape.[18] Internal cystic areas were seen in all the phyllodes cases.[18] In our study also all phyllodes cases showed irregular margins, septations, clefts, and cystic areas.

Intraductal papillomas are well-circumscribed polypoidal nodules that rarely exceed 3 cm in diameter. They are usually located in a cystically dilated duct. On MRI these lesions demonstrated complex solid cystic lesions in our study. Cystic areas and duct dilatations are hyperintense on T2W images; solid masses showed enhancement on post-contrast sequences. On histopathology, peripheral intraductal papillomas are not grossly visible. On microscopy, papillomas are complex and cellular and comprised of arborizing fibrovascular cores lined by an outer layer of luminal cells and an inner layer of myoepithelial cells.[1517]

Although this study could provide a correlation between the benign and malignant T2 hyperintense lesions, it was limited due to the small sample size and a single-center study.

CONCLUSION

T2WI hyperintensity may indicate edema, cysts, fat, fluid collection, hemorrhage, and tumor necrosis in the breast lesions. Usually malignant masses are hypointense on T2WI; however, a few malignancies, like mucinous cancers and tumor necrosis in high-grade tumors, may show hyperintense signal intensity on T2WI. Understanding the MRI characteristics on various sequences and pathogenesis can improve diagnostic accuracy in clinical practice. T2-weighted imaging sequence should be included in the abbreviated MRI protocol for characterization of the suspicious masses.

Ethical approval

The research/study approved by the Dr. D. Y. Patil Medical College, Hospital and Research Centre and Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, number DYPV/EC/174/17, dated 18/11/2017.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

REFERENCES

  1. , , , , , . Abbreviated protocol for breast MRI: Are multiple sequences needed for cancer detection? Eur J Radiol. 2015;84:65-70.
    [CrossRef] [PubMed] [Google Scholar]
  2. , , , , , . Radiologic and pathologic findings in breast tumors with high signal intensity on T2-weighted MR images. Radiographics. 2010;30:533-48.
    [CrossRef] [PubMed] [Google Scholar]
  3. , , , . Using T2-weighted sequences to more accurately characterize breast masses seen on MRI. AJR Am J Roentgenol. 2014;202:183-90.
    [CrossRef] [PubMed] [Google Scholar]
  4. , , , , , , et al. MRI of metaplastic carcinoma of the breast. AJR Am J Roentgenol. 2005;184:1274-8.
    [CrossRef] [PubMed] [Google Scholar]
  5. . The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology. 2007;244:356-78.
    [CrossRef] [PubMed] [Google Scholar]
  6. , , , , , , et al. The necrosis sign in magnetic resonance-mammography: Diagnostic accuracy in 1,084 histologically verified breast lesions. Breast J.. 2010;16:603-8.
    [CrossRef] [PubMed] [Google Scholar]
  7. , , , , , , et al. MRI features of mucinous cancer of the breast: Correlation with pathologic findings and other imaging methods. AJR Am J Roentgenol. 2016;206:238-46.
    [CrossRef] [PubMed] [Google Scholar]
  8. , , , , , , et al. Prognostic value of tumor necrosis based on the evaluation of frequency in invasive breast cancer. BMC Cancer. 2023;23:530.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  9. , , , , , , et al. Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy. Breast Cancer Res Treat. 2010;121:211-8.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  10. , , , , . Metaplastic carcinoma of the breast: Clinical, mammographic, and sonographic findings with histopathologic correlation. AJR Am J Roentgenol. 2002;178:1421-5.
    [CrossRef] [PubMed] [Google Scholar]
  11. , , , , , , et al. Imaging differences in metaplastic and invasive ductal carcinomas of the breast. AJR Am J Roentgenol. 2007;189:1288-93.
    [CrossRef] [PubMed] [Google Scholar]
  12. , , . Intracystic papillary carcinoma of the breast. Radiographics. 2010;30:2021-7.
    [CrossRef] [PubMed] [Google Scholar]
  13. , , , , , , et al. Papillary carcinoma of the breast: An overview. Breast Cancer Res Treat. 2010;122:637-45.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  14. MRI breast and advancements. In: , , eds. Imaging in management of breast diseases. Singapore: Springer; . In: editors
    [CrossRef] [Google Scholar]
  15. . Breast tumours. Vol 2. (5th). Lyon: International Agency for Research on Cancer; . ed Vol
    [Google Scholar]
  16. Rosai and Ackerman’s surgical pathology. Vol 2. (11th). Philadelphia, PA: Elsevier; . ed Vol
    [Google Scholar]
  17. Rosen’s breast pathology. (5th). Philadelphia: Lippincott Williams and Wilkins; . ed
    [Google Scholar]
  18. , , , , , , et al. Differentiation between phyllodes tumors and fibroadenomas based on mammographic sonographic and MRI features. Breast Care (Basel). 2016;11:123-7.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Show Sections